Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the initiation of production of The PBA Film Project (working title), the first-ever documentary to provide an intimate look at real people living with a little-known neurologic condition called PseudoBulbar Affect (PBA). The award-winning filmmaker team of The PBA Film Project includes co-directors Doug Blush and Lisa Klein (Of Two Minds) and producer Julian Cautherley (The Crash Reel).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7266955-avanir-pharmaceuticals-pseudobulbar-affect-pba-documentary/
The Council of Community Clinics (CCC), a premier consortium of primary care organizations in Southern California, today announced its new name and branding, Health Center Partners, the new name for its subsidiary formerly known as Community Clinic Health Network, Health Quality Partners, and the launch of Integrated Health Partners. Integrated Health Partners is a fully integrated primary health network designed to advance standards of care, improve outcomes and reduce costs for member community health centers. On the heels of its recently augmented executive leadership team and the addition of new member Community Health Systems, Inc., Health Center Partners today unveiled its innovative vision for meeting the evolving health needs of nearly 800,000 low-income and uninsured Californians at a launch ceremony in San Diego.
To view the multimedia release go to:
http://www.multivu.com/players/English/7774351-health-center-partners-unveils-community-health-vision/
Blu® Homes, Inc. (“Blu”), the leading builder of premium prefab homes, today announced the launch of its first rewards program. Find more information at www.bluhomes.com/rewards.
The rewards program, which launches November 26th, is open to anyone who loves the premium quality, award-winning design and superior convenience that Blu Homes offers. By sharing the rewards program through email and favorite social networks, participants can earn rewards as their friends move through the homebuying process. Rewards program participants can earn over $4,000 per referral and can redeem their rewards for Visa gift cards, Whole Foods Gift Cards, and Blu Homes Purchase Credit. Blu Homes will also be launching an exclusive realtor rewards program in early 2014.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53072-blu-homes-introduces-first-customer-rewards-program
There is a bankruptcy involving claims about exposure to asbestos-containing gaskets, packing, and equipment. Garlock Sealing Technologies LLC, The Anchor Packing Company, and Garrison Litigation Management Group, Ltd., along with representatives of asbestos claimants, have filed a new plan of reorganization (the “Plan”). Coltec Industries Inc is also part of the Plan. If claimants approve the Plan, Coltec will merge with a company known as OldCo, LLC, and that company will file a bankruptcy case. Together, these companies are referred to as the “Debtors.”
The gaskets and packing were used in places where steam, hot liquid, or acids moved through pipes, including industrial and maritime settings. The equipment included compressors, engines, pumps, transformers, and other equipment that may have had asbestos-containing components, such as gaskets or packing. The Coltec-related divisions or businesses that may have sold asbestos-containing products or equipment were Fairbanks Morse, Quincy Compressor, Central Moloney, Delavan, France Compressor, and Farnam.
To view the multimedia release go to:
http://www.multivu.com/players/English/7904751-garlock-coltec-asbestos-bankruptcy/
In the U.S., Americans’ perception of Mexico has reached a 10-year high, according to a recent Gallup, Inc. poll. The statistic further highlights the country’s record-breaking 2016 tourism year that saw more than 35 million international visitors - up 9% from the year prior - enjoying its world-class beaches and cultural offerings, according to the Mexico Tourism Board.
Credit for the country’s recent successes in tourism is largely due to the Mexican people - widely recognized as some of the friendliest and most welcoming in the world, and their centuries-old spirit of hospitality. Mexico Tourism Board’s internal consumer tracking studies showed more than 94 percent of visitors reported an experience that “exceeded their expectations” and 86 percent said they would “like to come back again” in the next six months– some of the highest scores in the industry, attesting to the popular Mexican adage, ‘mi casa es su casa’ (my home is your home).
To view the multimedia release go to:
https://www.multivu.com/players/English/8086151-mexico-tourism-gallup-poll/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
Nautilus Inc. (NYSE: NLS), a leader in innovative home fitness equipment, today unveiled new products, including the Bowflex Body™ nutrition line, Bowflex® SelectTech® 560 Dumbbells and a new line of Nautilus® cardio equipment.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7320551-nautilus-inc-launches-new-nutrition-strength-cardio-fitness-products-bowflex/
https://youtu.be/tDyhXD2DBZA Inc., well known for its annual lists of America’s fastest growing privately-held companies, has named Shopper Approved as the #192 company on its 2016 list. Being named as one of Inc. 500’s fastest growing private companies in America is a very prestigious, humbling award. During the past 3 years, Shopper Approved has experienced exponential growth of nearly 2,000% and continues to experience record numbers and is very excited about its future.
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
